Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.3%

1 terminated out of 12 trials

Success Rate

75.0%

-11.6% vs benchmark

Late-Stage Pipeline

25%

3 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results75% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (5)
P 3 (1)
P 4 (2)

Trial Status

Not Yet Recruiting4
Completed3
Recruiting3
Terminated1
Unknown1

Trial Success Rate

75.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (12)

Showing 12 of 12 trials
Showing all 12 trials

Research Network

Activity Timeline